Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle

Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, David Henderson, Michael Hudecek, Andreas Kremer, Janet Markman, Magdalena Nauerth, Helene Negre, Carmen Sanges, Philipp B. Staber, Rebecca Tanzi, Julio Delgado, Dirk H. Busch, Jürgen Kuball, Maik Luu, Ulrich Jäger

Open source

DOI: 10.3389/fimmu.2023.1303935
Published: 2023-12-22
Container: Frontiers in Immunology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2023.1303935,
  title = {Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle},
  author = {Benno Lickefett and Lulu Chu and Valentin Ortiz-Maldonado and Linda Warmuth and Pere Barba and Matteo Doglio and David Henderson and Michael Hudecek and Andreas Kremer and Janet Markman and Magdalena Nauerth and Helene Negre and Carmen Sanges and Philipp B. Staber and Rebecca Tanzi and Julio Delgado and Dirk H. Busch and Jürgen Kuball and Maik Luu and Ulrich Jäger},
  year = {2023},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2023.1303935},
  url = {https://doi.org/10.3389/fimmu.2023.1303935}
}

RIS

TY  - JOUR
TI  - Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
AU  - Benno Lickefett
AU  - Lulu Chu
AU  - Valentin Ortiz-Maldonado
AU  - Linda Warmuth
AU  - Pere Barba
AU  - Matteo Doglio
AU  - David Henderson
AU  - Michael Hudecek
AU  - Andreas Kremer
AU  - Janet Markman
AU  - Magdalena Nauerth
AU  - Helene Negre
AU  - Carmen Sanges
AU  - Philipp B. Staber
AU  - Rebecca Tanzi
AU  - Julio Delgado
AU  - Dirk H. Busch
AU  - Jürgen Kuball
AU  - Maik Luu
AU  - Ulrich Jäger
PY  - 2023
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2023.1303935
UR  - https://doi.org/10.3389/fimmu.2023.1303935
ER  -

APA

Lickefett, B., Chu, L., Ortiz-Maldonado, V., Warmuth, L., Barba, P., Doglio, M., Henderson, D., Hudecek, M., Kremer, A., Markman, J., Nauerth, M., Negre, H., Sanges, C., Staber, P. B., Tanzi, R., Delgado, J., Busch, D. H., Kuball, J., Luu, M., & Jäger, U. (2023). Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1303935

Source records

crossref · retrieved 2026-09-25T21:57:35.401Z